Understanding how these medications work inside the full weight ecosystem is an essential part of responsible, trauma-informed care
Common: may affect up to 1 in 10 people feeling dizzy upset stomach or indigestion burping gas (flatulence) bloating of the stomach inflamed stomach (gastritis) the signs include stomach ache, feeling sick (nausea) or being sick (vomiting) reflux or heartburn also called gastro-oesophageal reflux disease gallstones hair loss injection site reactions low blood sugar (hypoglycaemia) in patients with diabetes
AIFM1 mutations have been associated with wide spectrum of clinical phenotypes with X-linked recessive inheritance including a severe, early-onset mitochondrial encephalomyopathy with combined oxidative phosphorylation deficiency [155] , prenatal ventriculomegaly [156] , the Cowchock syndrome, an X-linked Charcot-Marie-Tooth disease (CMTX4) with axonal sensorimotor neuropathy, deafness and cognitive impairment [157] , auditory neuropathy spectrum disorder [158] , spondyloepimetaphyseal dysplasia with mental retardation [159] , and, more recently, cerebellar ataxia partially responsive to riboflavin [160]
In both cases, it provides significant weight loss benefits
Vai tr ca n khng phi l xy dng cu trc, m l bo v t bo v iu ha sc t da
Hypoglycaemia can occur with GLP-1 agonists, especially if used alongside sulfonylureas or insulin.3 Diabetics on GLP-1 Agonists can also present with episodes of hyperglycaemia and DKA.3 In such cases, it is important to look beyond the acute management and consider whether problems with regular access to medication is a contributing factor
